Tagungen und Workshops zum Thema Pharmakologie und Arzneimittelentwicklung

Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Organisatoren können kostenlos ihre Konferenzankündigungen veröffentlichen.

ALLE LÄNDER

1.
 
28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
ID
773640
Termin
28. Nov 2016 - 02. Dez 2016
Ort
München, Deutschland
Zusammenfassung
It is our great pleasure to announce that the   28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics   will take place in Munich.  Hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), the 2016 Symposium will bring together around 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology. As a one-of-a-kind Symposium at the forefront of drug development, it will enable participants to apply the latest findings and knowledge in their work and practice. This edition will also build on the success of the previous symposium which was widely praised for the quality of its programme, inspirational contributions and exclusive insights.
Verwandte Fachgebiete
2.
 
PharmaMed-2016 — International Conference on Medicinal and Pharmaceutical Chemistry
ID
812330
Termin
05. Dez 2016 - 07. Dez 2016
Ort
Dubai, Vereinigte Arabische Emirate
Zusammenfassung
International Conference on Medicinal and Pharmaceutical Chemistry is going to be held during December 5-7, 2016 at Crowne Plaza, Dubai, UAE. This scientific conference bring upon a new platform to share and discuss all the innovations in the Medicinal and Pharmaceutical Chemistry.
Kontakt
James Martin;     Tel.: [+1-302-231-6959];     Email: pharmamed@madridge.com
Themen
Molecular Modeling and Computer-Aided Drug Design, Drug Discovery from Synthetic and Natural Sources, Drug Design and Drug Delivery, Biopharmaceutics, Chemical Biology and Biophysics, Pharmacology, Toxicology and Pharmacogenomics, Pharmacodynamics and Pharmacokinetics, Pharmaceutical Analysis: Analytical Methods, Pharmaceutical Market, Antibiotics and Anti Cancer Drugs, Advances in Drug Discovery and Medicinal Chemistry, Pharmacology Applications in Medicine.
3.
 
4th Protein Expression, Purification & Characterization Conference
ID
825876
Termin
05. Dez 2016 - 07. Dez 2016
Ort
Boston, Vereinigte Staaten
Zusammenfassung
GTCbio is proud to present the 4th Protein Expression, Purification & Characterization Conference to be held on October 24-26, 2016 in Boston, MA. This meeting covers important topics including discussions on the expression of difficult proteins, new methods of purification, extended characterization of production cell lines, expression of difficult proteins, and new efficent analytical tools.
Kontakt
Kristen Starkey;     Tel.: [6262566405];     Email: infogtcbio@gtcbio.com
Themen
Protein Expression, Purification & Characterization
4.
 
BAC — 3rd Annual Re-Entering Antibacterial Discovery and Development Summit
ID
825020
Termin
07. Dez 2016 - 09. Dez 2016
Ort
Boston, Vereinigte Staaten
Zusammenfassung
By holding the Re-Entering Antibacterial Discovery and Development Summit, we at Cambridge Healthtech Institute are trying to contribute to the efforts to overcome the crisis of multidrug resistance, to revive the antibacterial pipeline, and to improve antimicrobial stewardship in the United States and worldwide. This Summit is designed as a forum for knowledge and opinion exchange among all stakeholders participating in discovery and development of new antibacterial agents. It includes several events listed below.
Kontakt
Pete DeOlympio;     Tel.: [781-972-5400];     Email: chi@healthtech.com
Themen
Compound validation, Preclinical development, Clinical phases, Regulatory concerns and pathways, Partnership seeking
5.
 
IMVACS — 11th Annual Immunization & Vaccine Summit
ID
825138
Termin
07. Dez 2016 - 09. Dez 2016
Ort
Boston, Vereinigte Staaten
Zusammenfassung
Globally, immunization has proven to be the gateway to health for millions, and continued investment in vaccine development provides a measureable return in reducing the burden of disease and safeguarding human development. Today, more than ever, vaccine technology remains at the forefront of the confrontation against infectious disease. Cambridge Healthtech Institute’s Eleventh Annual Immunization and Vaccine Summit will cover a range of topics in this evolving field, including the latest advancements and applications of vaccine technologies, development of effective vaccine adjuvants, and progress in DNA- and RNA-based vaccines.
Kontakt
Tel.: [781-972-5400];     Email: chi@healthtech.com
Themen
DNA- and RNA- Based Vaccines, Advances in Vaccine Technologies, Vaccine Adjuvants
Verwandte Fachgebiete
6.
 
Technical and Regulatory Writing for FDA-Regulated Industry
ID
842115
Termin
08. Dez 2016 - 09. Dez 2016
Ort
Boston, Vereinigte Staaten
Zusammenfassung
Regulatory professionals have to write highly technical documents for a variety of audience. These documents include reports, protocols, clinical trial and marketing approval applications, technical reports on studies, and communication documents. This workshop will address best practices, and regulatory strategies on how to write effective documents covering anywhere from simple issues such as minutes of meetings and correspondence notes, to highly sophisticated nonclinical and clinical study reports, and regulatory submissions to FDA, EMA, Health Canada, and other regulators. The trainers will provide practical tips using examples on how to organize and deliver information into clear and readable documents, and how to edit, format, present and publish technical regulatory documents for most favorable reception by the regulatory agencies. The workshop will also discuss rules for writing documents intended for electronic submission to regulatory agencies. This one-of-a-kind workshop will provide technical, practical, logical and logistical tips for regulatory writers of all levels of skills.
Kontakt
Peter Brown;     Tel.: [+1 410-501-5777];     Email: pbrown@fdamap.com
Themen
Medical Writing, Regulatory Writing, Technical Writing, Regulatory Training, Regulatory SOPs
7.
 
CDD — Computational Drug Development
ID
842578
Termin
13. Dez 2016 - 15. Dez 2016
Ort
Boston, MA, Vereinigte Staaten
Zusammenfassung
Computational Drug Development 2016 will bridge the gap between the application of computational tools for small molecule and biologic drug development. This meeting will bring together leading computational scientists from pharma, biotech, academia and software companies to evolve new solutions to focus the growing computational power on the richly accessible information generated in discovery and development.
Kontakt
Charlotte Harrison;     Email: info@hansonwade.com
Verwandte Fachgebiete
8.
 
Powerful Closed-loop CAPA - Meeting FDA Expectations
ID
852619
Beginn
14. Dez 2016
Ort
Palo Alto - online, Vereinigte Staaten
Zusammenfassung
This 90-minute webinar will show how you can implement a closed-loop CAPA system that meets CGMP requirements and U.S. FDA expectations. You will learn simple, but powerful, tools and methods that you can use regularly and systematically to define and resolve root causes, not just symptoms.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
FDA Compliant CAPA, FDA Expectations for Root Cause Analysis, Failure Investigation Methodology, GMP Audit, Non-conformance, OOS resolution, Complaint Handling, Adverse Event Reporting and Resolution
9.
 
Understanding and Remediating Corrosion Problems during Parenterals Manufacturing
ID
852551
Beginn
14. Dez 2016
Ort
Palo Alto - online, Vereinigte Staaten
Zusammenfassung
In this two-hour webinar you will learn how to recognize problems related to corrosion, how to diagnose their specific causes, and how to remediate them. This webinar surveys the range of corrosion-mediated failure modes of parenteral solution manufacture. The roles of physical factors such as temperature, humidity, oxygen as well as formulation variables such as chloride level, pH, and inorganic metals will be discussed in this session.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
ICH Q3D, Elemental Impurities Regulations, Corrosion, elemental impurity guidelines, laboratory scale simulations, metallurgical tests
10.
 
Effective Deviation Investigators Under GMP
ID
852583
Beginn
15. Dez 2016
Ort
Palo Alto - online, Vereinigte Staaten
Zusammenfassung
This 120 minute training course will help attendees understand the fundamental steps of a deviation investigation with focus on using facts and objective evidence to arrive at root cause and CAPA. Learn how to identify and avoid potential pitfalls during deviation investigations.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Deviation, CAPA, OOS, deviation investigations, GMP requirement, Out of Specification, corrective action, 483
11.
 
The Veterinary Drug Approval Process and FDA Regulatory Oversight
ID
852558
Termin
15. Dez 2016 - 16. Dez 2016
Ort
Kansas City, Vereinigte Staaten
Zusammenfassung
The U.S. Food and Drug Administration’s Center for Veterinary Medicine or CVM is responsible for the approval of veterinary drug products intended for both family pets and food-producing animals. However, FDA does not regulate all products intended for animal use. Jurisdiction over animal products including licensed biologics such as vaccines is shared with a number of other federal agencies. For example, animal vaccines, animal disease diagnostic devices and some animal biologics are regulated by the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service or APHIS; and products such as flea and tick collars are regulated by the Environmental Protection Agency.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
FDA veterinary drug approval process, center for veterinary medicine, new animal drug application, investigational new animal drug (INAD) file, animal disease diagnostic devices, veterinary medicine regulations, veterinary drug user fees
12.
 
The Benefit/Risk Ratio: Pharmacovigilance, Medical And Regulatory Converge
ID
852491
Termin
15. Dez 2016 - 16. Dez 2016
Ort
Zürich, Vereinigte Staaten
Zusammenfassung
In this two day workshop conference we will review requirements of EMA and EU regulatory authorities. The course will focus on the laws and regulations for Pharmacovigilance during Pre-marketing and Post-marketing (EMA, GVP, ICH). Attendees will get different points of views on Regulatory, Scientific, Ethical, Marketing and understanding about the role of GVP (Good Vigilance Practice). You will learn to design complete strategy for PSUR/PBRER.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Pharmacovigilance (PV) Training, learn GVP (Good Vigilance Practice),
13.
 
Effective Design, Validation and Routine Maintenance of Pharmaceutical Gases
ID
852567
Termin
15. Dez 2016 - 16. Dez 2016
Ort
Philadelphia, Vereinigte Staaten
Zusammenfassung
Pharmaceutical gases such as Compressed, Nitrogen Argon gas systems used for the production of finished pharmaceutical or other types of products may either have direct or indirect impact to the finished products. These gases are also used for other medical and non-routine processes hence understanding the design, validation, routine monitoring, data management, failure investigations, regulations and applicability of each type of gas system ensures compliance to the required regulations. A detailed technical understanding of how to perform these critical steps during the initial evaluation or re-evaluation of a new, modified or existing gas system will eliminate expensive failure or remediation issues, inability to perform validation as well as routine testing and maintenance issues which ultimately impact or delay the release of the affected product.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
pharmaceutical gas programs, ISO 8573, FDA requirements for pharma gas, microbiological testing program for pharma gas, pharmaceutical gas testing trending program, analytical gas testing, gas testing trend reports
14.
 
BTS — Biotech Showcase™ 2017
ID
844956
Termin
09. Jan 2017 - 11. Jan 2017
Ort
San Francisco, Vereinigte Staaten
Zusammenfassung
Biotech Showcase™ is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.The 2016 event showed a substantial increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. Now in its ninth year, Biotech Showcase 2017 is expected to feature presentations by close to 350 public and private companies and attract more than 2,600 attendees. The event will run a full program of topical plenary sessions and workshops, including special-focus two-day events Digital Medicine Showcase and Medtech Showcase.
Kontakt
Camille Del Carmen;     Tel.: [+1 760 930 0500];     Email: cdelcarmen@ebdgroup.com
Themen
Biotechnology Life Science Molecular Diagnostic Personalized Medicine Pharmaceutical Specialty Pharma
Verwandte Fachgebiete
15.
 
Pre-Filled Syringes Europe 2017
ID
839108
Termin
18. Jan 2017 - 19. Jan 2017
Ort
London, Großbritannien
Zusammenfassung
Now leading the path in presenting the industry with all the necessary updates on injectable devices, SMi Group returns to Central London on 18th & 19th January 2017 to proudly host the 9th annual conference and exhibition: Pre-Filled Syringes Europe. Pre-Filled Syringes Europe 2017 will once again gather an audience of senior scientists, device manufacturers and PFS market professionals, providing a focal point to discuss the latest innovations and developments in pre-filled syringes; as well as hone in on industry challenges and regulatory compliance. The best line-up yet will include speakers from Novartis, MHRA, USB, Sanofi, GSK, Glenmark, Sandoz, Teva, Novartis, Janssen Pharmaceuticals, F. Hoffmann-La Roche, Boehringer Ingelheim and more!
Kontakt
Teri Arri;     Tel.: [2078276000];     Email: tarri@smi-online.co.uk
Themen
prefilled syringe, pre-filled syringe, autoinjector, human factors, device development, innovation, strategy, extractables, leachables, patient safety, compliance, biosimilar, parenteral, packaging, combination products, lyophilisation, freeze drying, injectable, injectable devices, syringe, extractables and leachables, E&L, PFS, drug device, drug delivery, combination products, sterilization, needle, component, glass syringe, cop syringe, container, formulation, device development, human factors, manufacturing, device technology, medical device, parenteral drug, plastic, qbd
16.
 
CGT World — Cell & Gene Therapy World
ID
845019
Termin
18. Jan 2017 - 20. Jan 2017
Ort
Miami, Vereinigte Staaten
Kontakt
Carina Hunter;     Tel.: [+44(0)2073847897];     Email: team@phacilitate.co.uk
Themen
cell therapy, gene therapy, clinical trials, regulatory, cord blood, bioprocessing, r&d, strategic
17.
 
Immuno World 2017 — Immunotherapy World 2017
ID
844930
Termin
18. Jan 2017 - 20. Jan 2017
Ort
Miami, Vereinigte Staaten
Zusammenfassung
After years of posting impressive clinical results and pushing analyst projections to greater and greater heights, immuno-oncology has solidified its status as the most exciting development in cancer treatment for a long time. Now that checkpoint inhibitors have uncloaked cancer cells, drug developers are investigating dozens of immune drug cocktails (everything from CAR-T to antibodies, vaccines and other cellular therapies) to find well-tolerated treatments which could become the first-in-line to fight cancer in patients.
Kontakt
Carina Hunter;     Tel.: [+44(0)2073847897];     Email: team@phacilitate.co.uk
Themen
immuno, immunotherapy, oncology, R&D, regulatory, supply chain, logistics, lab sessions,
Verwandte Fachgebiete
18.
 
Keystone Symposia: Biobetters and Next-Generation Biologics: Innovative Strategies for Optimally Effective Therapies
ID
830095
Termin
22. Jan 2017 - 26. Jan 2017
Ort
Snowbird, Utah, Vereinigte Staaten
Zusammenfassung
The purpose of this meeting is to examine different approaches for treatment of cancer and other diseases (e.g., fibrosis, autoimmunity and inflammatory diseases). The program will provide insights from academic and industry scientists on innovative biologics technologies and treatment strategies for ameliorating disease in an effort to identify synergies and opportunities to cross-fertilize approaches. Furthermore, the meeting includes perspectives from the US Food & Drug Administration and how the outlined strategies will impact the drug review and approval process. The intention is to better inform meeting attendees of current/future strategies for treating disease and best practices for transforming concepts into approved drugs.
Kontakt
Attendee Services;     Tel.: [970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Themen
Cancer, drug discovery, immunology
19.
 
Drug Development, Pharmacokinetics and Imaging
ID
828762
Termin
23. Jan 2017 - 27. Jan 2017
Ort
Oxford, Großbritannien
Zusammenfassung
The Drug Development, Pharmacokinetics and Imaging module is a one-week module of the MSc in Experimental Therapeutics programme. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the module will be led by Dr Paul Brennan, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Kontakt
Course Administrator;     Tel.: [+44(0) 01865 286955];     Email: expther@conted.ox.ac.uk
20.
 
FDA Scrutiny of Promotion and Advertising Practices
ID
852566
Termin
24. Jan 2017 - 25. Jan 2017
Ort
San Francisco, Vereinigte Staaten
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
fda's advertising and promotion requirements, fda regulations for labelling, fda warning letter, fda legal authority, ftc, mass media, doj, off label, fda guidance, custom device promotion, fda compliance seminar
21.
 
11th ANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE
ID
843048
Termin
12. Feb 2017 - 14. Feb 2017
Ort
San Diego, Kalifornien, Vereinigte Staaten
Zusammenfassung
This didactic conference will educate scientists on the processes of translating basic research into novel therapies and will leave participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug.
Kontakt
Sara Classen;     Tel.: [Tel: +1.212.901.8009];     Email: sclassen@alzdiscovery.org
Themen
Neurodegeneration, Drug discovery, CNS, Alzheimer’s Disease
22.
 
SBCADD`2017 — 9th National Symposium cum Workshop on “Recent Trends in Structural Bioinformatics and Computer Aided Drug Design”
ID
853060
Termin
14. Feb 2017 - 17. Feb 2017
Ort
Karaikudi, Indien
Zusammenfassung
SBCADD’2017 would like to take this wonderful privilege to invite you all to the 9thNational Symposium cum Workshop” going to be held during February 14th – 17th 2017, on the theme of “Recent Trends in Structural Bioinformatics and Computer Aided Drug Design” seeks to continue the good synergy obtained in the previous edition, providing a discussion forum from scientists, researchers, students and industrials about the latest ideas and realizations in the foundations, theory, models and applications for interdisciplinary and multidisciplinary research encompassing disciplines of Structural Biology, Molecular Biology, Structural Bioinformatics, Computer Aided Drug Design and Pharmacogenomics. In recent years, Computational Biology and Medical Informatics have seen significant advances driven by computational techniques making Bioinformatics and Computational Biology among the most vibrant research areas that could accelerate translational research comprising of the development and discovery of drugs against combating diseases that could enhance the livelihood and life expectancy of the individuals. The aim of SBCADD’2017 is to create a friendly environment that could lead to the establishment or strengthening of scientific collaborations and exchanges among attendees, and therefore, participation at SBCADD’2017 would provide an excellent opportunity to keep up with the cutting-edge research in such enlivening topics mentioned above and to network with other members of our community. We cordially invite you to submit abstract and participate in Symposium cum Workshop.
Kontakt
Dr. Sanjeev Kumar Singh;     Tel.: [+91 – 4565 - 223342];     Email: dbiconf@gmail.com
Themen
SBCADD'2107, Sanjeevslab, Dr. Sanjeev Kumar Singh, sanjeevslab.org, bioinfoau.org
23.
 
Biologistics World Asia 2017
ID
827110
Termin
15. Feb 2017 - 16. Feb 2017
Ort
Singapore, Singapur
Zusammenfassung
Biologistics World Asia will be the MOST Targeted event in Asia that focuses on cold- chain logistics for biomedical products. Bioplogistics World Asia 2017 will be attended by decision makers from regional and international biopharmaceuticals and biotechnology firms, top CMOs and CROs, government organizations and key global and Asian regulators. It’s your one stop solution to reach out to Asia’s logistics and supply chain industry!
Kontakt
Andrew Darwitan;     Tel.: [+65 3109 0156];     Email: andrew.darwitan@imapac.com
24.
 
World ADC Berlin — The 7th Annual World ADC Berlin
ID
845077
Termin
20. Feb 2017 - 22. Feb 2017
Ort
Berlin, Deutschland
Kontakt
Jenny Barlow;     Tel.: [+1 212 537 5898];     Email: info@hansonwade.com
Themen
Antibody drug conjugates, Antibody-drug conjugates, ADCs/ADC
Verwandte Fachgebiete
25.
 
Vaccines-2017 — International Conference on Vaccines-2017
ID
811294
Termin
20. Feb 2017 - 22. Feb 2017
Ort
Baltimore, Vereinigte Staaten
Zusammenfassung
This scientific conference will bring an opportunity to share potential benefits and limitations of vaccines in preventing and control of infectious and non-infectious diseases thereby enhancing the quality and longevity of life.Vaccines 2017 mainly showcases comprehensive approaches in Vaccines and research, virology. vaccine conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations
Kontakt
James Martin;     Tel.: [1-302-231-6959];     Email: Vaccines@madrige.com
Themen
Vaccines, virology, Infectious and non infectious diseases, Therapeutic Medicines
Verwandte Fachgebiete
26.
 
12th Annual Biomarkers Congress
ID
839687
Termin
21. Feb 2017 - 22. Feb 2017
Ort
Manchester, Großbritannien
Zusammenfassung
Oxford Global is proud to present its 12th Annual Biomarkers Congress taking place on the 21-22 February 2017 in Manchester. Our renowned congress will bring together over 300 attendees, speakers and vendor companies from pharmaceutical and biotechnology companies as well as academia.

In line with the current industry trends, the flagship event this year focuses on the discovery, development and clinical development of biomarkers in Autoimmune, Immuno-oncology, Neuroscience, Oncology as well as Cardiovascular, Rheumatology, COPD, Rare Diseases and Microbiome. Our expert speakers will also cover innovations in Biomarker research such as imaging biomarkers and assay development, big data challenges in biomarker research, new advances in biomarker technologies and platforms; insights into the human proteome atlas, population genetics, systems biology and their implications in Biomarker development. Do not miss out on gaining insights on the role of biomarkers in clinical development, clinical trials and clinical diagnostics.

Kontakt
Danielle Dalby;     Tel.: [+44 1865248455];     Email: d.dalby@oxfordglobal.co.uk
Themen
Clinical development, clinical trials, clinical diagnostics, innovative biology, microRNA’s, CTCs, liquid biopsies and free circulating RNA & DNA.
Verwandte Fachgebiete
27.
 
DDRI — 3rd Drug Discovery Re-Invented (Emerging Role of Biotechs, Academics and Non-Profits)
ID
843028
Termin
21. Feb 2017 - 24. Feb 2017
Ort
Cancun, Mexiko
Kontakt
Jack Peters;     Tel.: [01638 724137];     Email: jack@fusion-conferences.com
Themen
drugs, drug, drug discovery, pharma, pharmacology, research, pipelines, government, academic, non-profits, biotech, pharmaceutical, innovation, natural products, drug development, structure, modeling, approaches
28.
 
2nd Annual Lyotalk 2017 Asia — Pacific Largest conference in Freeze drying / Lyophilization
ID
852235
Termin
23. Feb 2017 - 24. Feb 2017
Ort
HYDERABAD, Indien
Zusammenfassung
The event covers a wide spectrum from formulation, Development, Production, manufacturing and regulatory affairs topics such formulation strategies, Scale-up, cycle development & optimization, Regulatory compliance, Quality by Design (QbD) , PAT process design, Ice Nucleation, Case studies & troubleshooting, New developments in freeze drying, Process development for generics, proteins, biologics and vaccines.
Kontakt
Linda Clark;     Tel.: [+912265344333];     Email: linda.clark@biotrains.com
Themen
The main topics will include • Formulation strategies • Scale-up, cycle development & optimization • Regulatory compliance • Quality by Design (QbD) • PAT process design, • Ice Nucleation • Case studies & troubleshooting • New developments in freeze drying • Process development for generics, proteins, biologics and vaccines.
29.
 
Frontiers in Cancer Immunotherapy
ID
824447
Termin
27. Feb 2017 - 28. Feb 2017
Ort
New York, NY, Vereinigte Staaten
Zusammenfassung
This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. James Allison, Executive Director of the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center and a pioneer in the field of cancer immunotherapy, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including: the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.
Themen
Immunotherapy, Oncology, Immunology, Therapeutics, Clinical Trials, Vaccines, Diagnostics, Biomarkers, Genomics, Epigenomics, Epigenetics, Drug Discovery, Cancer
Verwandte Fachgebiete
30.
 
Keystone Symposia - Kinases: Next-Generation Insights and Approaches
ID
825355
Termin
05. Mär 2017 - 09. Mär 2017
Ort
Breckenridge, Colorado, Vereinigte Staaten
Zusammenfassung
Decades of both basic and applied research have unequivocally established the importance the kinase family of phosphotransferase enzymes in virtually every aspect of organismal homeostasis. From the initial characterization of ATP-dependent phosphorylation in the liver by Gene Kennedy in 1954, our understanding of the family has grown from the diverse perspectives of enzymology, biochemistry, biophysics, structural biology, genetics, cellular biology, pharmacology and physiology. Importantly, these advancements have yielded transformative therapeutic approaches to disease, most notably in the field of cancer where kinase inhibition is helping to fulfill the promise of precision medicine. Yet even today, our perspectives on the complexity of this class of enzymes continues to evolve, and many of the most exciting advancements in the field are being made by applying modern-day insights and technological approaches to the diverse roles the enzymes can play in health and human disease. This meeting will be devoted to exploring this innovative leading edge of kinase research, and will bring together leading researchers from academic, clinical and pharmaceutical settings to explore and define the new horizons in the field of kinase biology.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
Kinases, Drug Discovery, Kinase Signaling, Kinase Inhibitor
31.
 
Pharmacodynamics, Biomarkers and Personalised Therapy
ID
828761
Termin
06. Mär 2017 - 10. Mär 2017
Ort
Oxford, Großbritannien
Zusammenfassung
The Pharmacodynamics, Biomarkers and Personalised Therapy course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the week will be led by Dr Elaine Johnstone, Senior Research Fellow at the University of Oxford, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists, as well as a practical visit to one of Oxford's research laboratories.
Kontakt
Course Administrator;     Tel.: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
32.
 
Pharmaceutica 2017 — 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
ID
833011
Termin
13. Mär 2017 - 15. Mär 2017
Ort
London, Großbritannien
Zusammenfassung
Pharmaceutica 2017 provides the perfect platform for just this as an interactive and engaging 3-day event: unique in format, content, networking and engagement. The event brings together truly innovative thinkers who are leading the way through trialing new disruptive solutions and rethinking the conventional formulation and delivery mind-set and will help you to better understand how to develop the right formulation and delivery strategy with a strong scientific, clinical and commercial mind set and how innovative scientific techniques, emerging technologies and innovative devices can transform formulation and drug delivery.
Kontakt
Renaldo Howell;     Tel.: [+1 702 508 5200];     Email: renaldohowell179@gmail.com
Themen
Pharmaceutics, Drug Delivery, Targeted Drug Delivery, Formulation, Pharmaceutical nanotechnology, nanomedicine, smart drug delivery
33.
 
Health Economics for Non-Health-Economists
ID
834374
Termin
16. Mär 2017 - 17. Mär 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
34.
 
2nd Personalized Medicine Conference
ID
853109
Termin
17. Mär 2017 - 20. Mär 2017
Ort
Cancun, Großbritannien
Zusammenfassung
Join us for the 2nd Personalized Medicine conference taking place from 17-20 March 2017 in Cancun, Mexico to discuss to discuss precision diagnostics, cancer genomics, biomarkers, computational imaging, bioinformatics and data analytics/big data. The personalized medicine space has been defined by recent regulatory approvals of targeted therapeutics in oncology and co-developed diagnostics used in patient selection. However, a broader view of personalized medicine encompasses other disease areas, newer therapeutic regimens, new therapeutic platforms and broad computational approaches. This conference will weave together many of these new approaches and their relevance to personalized medicine.
Kontakt
Laura Trundle;     Tel.: [+44 (0) 1638724137];     Email: laura@fusion-conferences.com
Themen
precision diagnostics, cancer genomics, biomarkers, computational imaging, bioinformatics and data analytics/big data.
Verwandte Fachgebiete
35.
 
Keystone Symposia - Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity
ID
825213
Termin
19. Mär 2017 - 22. Mär 2017
Ort
Tahoe City, California, Vereinigte Staaten
Zusammenfassung
There are fundamental aspects of metabolic homeostasis that are regulated differently in males and females, and influence both the development of diabetes and obesity and the response to pharmacological intervention. Still, most preclinical researchers avoid studying female rodents due to the added complexity of research plans. The consequence is the generation of data that risks being relevant to only half of the population. This is a timely moment to study sex differences in diseases as NIH leadership has asked scientists to consider sex as a biological variable in preclinical research, to ensure that women get the same benefit of medical research as men. The goal of this meeting is to fill a need in the scientific community by connecting interdisciplinary groups of scientists who normally would not have an opportunity to interact. This group includes investigators studying sex differences, the role of sex hormones, the systems biology of sex and the genetic contribution of sex chromosomes to metabolic homeostasis and diseases. Leaders of the pharmaceutical industry will present their views on sex-specific drug discovery. The meeting is expected to generate new knowledge and ideas on the importance of gender biology and medicine from a molecular standpoint to the population level, and to provide the methods to study them. It is intended to be a catalyst of a process that will lead to gender-specific treatments of metabolic diseases.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
sex, gender, metabolic homeostasis, diabetes, obesity, sex differences, estrogens, androgen, drug design, gender-specific medicine, metabolomics, genetics
Verwandte Fachgebiete
36.
 
Keystone Symposia - Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology
ID
825285
Termin
19. Mär 2017 - 23. Mär 2017
Ort
Whistler, British Columbia, Kanada
Zusammenfassung
The fields of cancer immunology and immunotherapy continue to make great strides in providing both a comprehensive understanding of the basic mechanisms underlying tumor-immune system interactions and applying this knowledge to the development of effective immune-based cancer therapies. This Keystone Symposia meeting is organized to highlight recent insights into the complex roles of immune components and pathways in controlling or alternatively promoting cancer and to showcase recent uses of cancer vaccines, checkpoint blocking strategies, adoptive cell therapies and cellular engineering approaches, either as mono- or combinatorial therapies, that have resulted in durable, effective and safe therapeutic responses to an increasing number of cancer patients. Part of the meeting will also focus on new, developing technologies that are likely to expand our capacity to monitor the effects of cancer immunotherapy with a precision, refinement and at a level that has not been possible in the past.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
cancer immunology, cancer immunotherapy, immunosuppressive cells, tumor microenvironment, immune checkpoints, combinatorial approaches, cancer vaccines, inflammation, cellular engineering, nex-gen technologies
Verwandte Fachgebiete
37.
 
ITOC4 — 4th ImmunoTherapy of Cancer Conference
ID
848831
Termin
20. Mär 2017 - 22. Mär 2017
Ort
Prag, Tschechische Republik
Zusammenfassung
The ITOC series of conferences is the premier meeting for education, scientific exchange and networking within cancer immunotherapy. The fourth edition (ITOC4) will take place on Prague, Czech Republic, from 20 to 22 March 2017. It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research. The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.
Kontakt
Catherine Tomek (Congress Office);     Tel.: [+431405138318];     Email: itoc@medacad.org
Themen
Preclinical models, Co-stimulatory agonists and co-inhibitory antagonists, Immunogenomics, Therapeutic modulation of immune checkpoints, Combination therapy, Anti-cancer vaccines, Engineered T-cell therapy, Monitoring of immunotherapy
Verwandte Fachgebiete
38.
 
8th Annual Biotherapeutics Analytical Summit
ID
829838
Termin
20. Mär 2017 - 23. Mär 2017
Ort
Bethesda, Vereinigte Staaten
Zusammenfassung
Today’s complex biologics formats and ever increasing regulatory demands necessitates that companies come up with the most efficient, accurate and robust analytical methods to characterize a molecule; find the most effective tools to assess the molecule’s physico-chemical properties to optimize its druggability and developability, and to ensure that the end product is consistently safe and efficacious when comparing between batches or between biosimilars and innovators. When it comes to batch-to-batch variation, as the saying goes, “process is the product” – process analytics and quality control are thus of biggest concern to manufacturers and regulators alike.
Kontakt
Bethany Gray;     Tel.: [781-972-5400];     Email: chi@healthtech.com
39.
 
Keystone Symposia - HIV Vaccines
ID
825214
Termin
26. Mär 2017 - 30. Mär 2017
Ort
Steamboat Springs, Colorado, Vereinigte Staaten
Zusammenfassung
Despite great progress in preventing and treating HIV, new infections continue to plague communities around the world, and the need for an HIV vaccine is as urgent as ever. Several large cohorts of HIV-infected individuals have enabled tremendous advances over the past five years in understanding immune responses to natural HIV infection. These advances have included the isolation of broad and potent anti-HIV antibodies, defining their developmental pathways, the generation of native-like Env trimers for immunization, and high-resolution structures of the envelope glycoprotein in complex with bnAbs. By 2017, many of these discoveries will have enabled new concepts to transition into human clinical trials, including passive monoclonal antibody therapy and novel immunization approaches. These platforms, incorporating improved technology for monitoring immune responses, will drive major advances in the vaccine field. This HIV Vaccines meeting will present the latest results from human clinical studies, along with the cutting-edge basic science behind such trials to highlight approaches that may lead to an HIV vaccine, and also reveal the molecular underpinnings of B and T cell-mediated immunity.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
HIV Vaccines, HIV, natural infection, transmission biology, immunogen platforms, b-cells, t-cells,
Verwandte Fachgebiete
40.
 
Drug Discovery 2017 — Drug Discovery 2017
ID
853327
Termin
27. Mär 2017 - 28. Mär 2017
Ort
London, Großbritannien
Zusammenfassung
The conference aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges. Highlights include: discussions on the use of CRISPR/Cas9 Technology in target discovery, hit finding and translational studies; optimising the success of phenotyping screening; exploring whether translational medicine is capable of increasing success rate in pharma; insights into receptor activation from agonist and antagonist structures; and applications of enabling chemistry technology to the acceleration of the drug discovery process. Speakers include Sanofi, Takeda, AstraZeneca, Merck Serono, Novartis, AbbVie, GSK, Johnson & Johnson, UCB Pharma, Eli Lilly & Co and more. Register at http://www.drug-discovery.co.uk/coms
Kontakt
Honey de Gracia;     Email: hdegracia@smi-online.co.uk
Themen
drug discovery, drug development, stem cells, precise-genome editing, CRISPR/Cas9, phenotypic screening, translational medicine, receptor activation, agonist structures, drug design, computer aided drug design, fragment based drug design, SBDD, FBDD, CADD
41.
 
ICBMB 2017 International Conference on Biochemistry and Molecular Biology 3-5 April 2017, Munich, Germany
ID
853073
Termin
03. Apr 2017 - 05. Apr 2017
Ort
München, Deutschland
Kontakt
Andrea Berg;     Tel.: [adeo.office@gmail.com];     Email: adeo.office@gmail.com
Themen
biology, biochemistry, molecular biology
42.
 
MESMAP-3 — The Third Mediterranean Symposium on Medicinal and Aromatic Plants
ID
811570
Termin
13. Apr 2017 - 16. Apr 2017
Ort
Girne (Kyrenia), Cyprus, Türkei
Verwandte Fachgebiete
43.
 
Pharma Tech 2017 — International Conference and Exhibition on Pharmaceutical Development and Technology
ID
828975
Termin
24. Apr 2017 - 26. Apr 2017
Ort
Dubai, Vereinigte Arabische Emirate
Zusammenfassung
ConferenceSeries LLC is a renowned organization that organizes highly notable pharmaceutical conferences and healthcare conferences throughout the globe. ConferenceSeries LLC invites all the participants from all over the world to attend “International Conference and Exhibition on Pharmaceutical Development and Technology ”during April 24-26, 2017 Dubai, UAE.This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Pharma Tech 2017 is a latest technological platform to aid efficient drug discovery and development. These platforms range from vast chemical libraries, ultra-high throughput screening and huge genetic databases in discovery, to predictive toxicology platforms and even deep-seated knowledge of particular therapeutic areas in development. New research platforms designed to help its teams of investigators focus on a set of key strategic initiatives that will help guide their multibillion-dollar drug development program to advance new medicines that can get ahead of a disease and prevent it from taking a toll.
Kontakt
Mythrei Syria;     Tel.: [+1-702-508-5200];     Email: pharmatech@pharmaceuticalconferences.com
Themen
Pharmaceutical Technology, Pharmaceutical Technology Conferences, Pharma Tech Meetings, Pharma Tech Symposiums, Pharma Tech Exhibitions, Pharma Tech 2017 Conferences, Pharma Tech Conferences Dubai, Pharma Tech meetings USA, Pharma Tech Conferences euro
Verwandte Fachgebiete
44.
 
Corvus Global Events — Digi-tech Pharma 2017
ID
850938
Termin
25. Apr 2017 - 26. Apr 2017
Ort
London, Großbritannien
Zusammenfassung
Digital Pharma World 2017, will provide a platform to all its participants an opportunity to interact, share and discuss the digitalization of Pharma industry. It will allow its participants to discuss the various challenges faced, new strategies, case studies and use of innovative ideas in the field of digital pharma. Also, to stay updated on the latest trends in digital, social media and mobile strategies required the overcome the obstructions in the transformation. This conference will allow IT leaders to share their technologies and strategies to help the pharma industries. The conference will offer opportunities to encourage partnerships and collaborations
Kontakt
Fazmina Fajjuu;     Tel.: [+44 (0) 207 096 0786];     Email: fazmina@corvusglobalevents.com
Themen
Key Highlights of the conference: • Digitally enabled business models • Big data analytics and pharma • Internet of things and pharma • Translational Informatics • Policy changes required for ensuring smooth transition • Ensuring regulatory compliance during the transformation • Digital marketing trends • Integrating Multichannel marketing and closed loop marketing • Digitalization of R& D using Big Data and IoT • New smart devices in manufacturing and supply chain • Clinical trials and digital world • Data management • Tools and strategies to engage with HCPs and patients and to win their confidence • Encouraging a customer–centric approach at all levels • Unrealized innovative potentials of digital era that pharma needs to focus on . Attendees includes VPs, GMs, Directors, Heads and Managers of • Pharma sales and Marketing • E-marketing • Digital innovative strategic planning • Regulatory and pharmacovigilance • IT consultants • Clinical trials and data management • Translational informatics • Data storage and analysis • Contract outsourcing service providers • Multi-channel Management • Health care professionals • Health IT professionals
45.
 
Keystone Symposia - Modeling Viral Infections and Immunity
ID
825353
Termin
01. Mai 2017 - 04. Mai 2017
Ort
Estes Park, Colorado, Vereinigte Staaten
Zusammenfassung
Viral infection modeling has provided insights into the pathogenesis and treatment of HIV, HCV, HSV-2, CMV and other viruses. It has had impact in revealing the lifespan of infected cells, how rapidly virus is produced and cleared from the circulation, and the means for evaluating the effectiveness of antiviral treatments. HIV remains a global health threat and there is great interest in revealing features of the main HIV reservoir, latently infected cells and mechanisms of reducing the size of this reservoir by pharmacological means. Other important gaps in knowledge revolve around the cell-mediated and humoral immune responses to HIV, important for generating vaccines and broadly neutralizing antibodies as therapeutics, topics that will be discussed. Further, viral infections generally occur in tissues and thus the meeting will discuss imaging techniques and methods of modeling and analyzing spatial infection data, the role of tissue-resident memory cells, and important features of immune regulation, such as immune exhaustion, cytokine signaling between cells, and viral subversion of innate responses and escape from adaptive responses. The meeting will highlight what we believe are significant hurdles to curing viral infections and will bring together experimental virologists, physician scientists and modelers of various types and experience, groups that do not normally meet. It should foster new collaborations between experimentalists and theoreticians, and between theoreticians working on different viral infections or different aspects of viral infections, as well as help young scientists formulate new research directions and make connections with established senior scientists.
Kontakt
Tel.: [1 800-253-0685];     Email: info@keystonesymposia.org
Themen
modeling viral infections, immunity, viral infection, Modeling Immune Regulation, HIV, Modeling Cellular Immune Responses, Spatial Aspects of Infection
Verwandte Fachgebiete
46.
 
Adverse Drug Reactions, Drug Interactions and Pharmacovigilance
ID
828760
Termin
08. Mai 2017 - 12. Mai 2017
Ort
Oxford, Großbritannien
Zusammenfassung
The Adverse Drug Reactions, Drug Interactions and Pharmacovigilance course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the teaching will be led by Dr Michael Theodorakis, Radcliffe Department of Medicine, University of Oxford, and will feature face-to-face lectures and tutorials from some of the country's leading clinicians and scientists.
Kontakt
Course Administrator;     Tel.: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
47.
 
The Health Technology Assessment Course - Trends & Opportunities in Europe
ID
834346
Beginn
09. Mai 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
48.
 
Orphan Drugs and Rare Diseases Europe 2017
ID
852632
Termin
15. Mai 2017 - 16. Mai 2017
Ort
Berlin, Deutschland
Zusammenfassung
SMi is proud to announce the return of their 6th annual Orphan Drugs event to Berlin on the 15th -16th May 2017! The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019.* With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market.
Kontakt
Kyra Williams;     Email: kwilliams@smi-online.co.uk
Themen
Orphan Drugs, Rare Diseases, Market Access, Pricing and Reimbursement, Patient Recruitment
49.
 
Gavin Conferences — International Conference on Pharmaceutical Drugs
ID
848184
Termin
15. Mai 2017 - 17. Mai 2017
Ort
Dubai, Vereinigte Arabische Emirate
Zusammenfassung
Gavin Conferences invites participants from all over the world to attend “International Conference on Pharmaceutical Drugs” to be held on May 15-17, 2017 at Dubai, UAE. The conference is organized with the theme “Bridging the gap between Drugs and Disease Prevention” which includes keynote presentations from world class scientists and researchers, Oral talks, Poster presentations, B2B meetings and Exhibitions. World-renowned speakers, the most recent techniques and updates in the field of Pharmaceutics are hallmarks of this conference.
Kontakt
Daniel;     Tel.: [6303970234];     Email: danielgavin456@gmail.com
Themen
Pharmaceutical Drug Development,  Drug Formulation, Evaluation, Drug Discovery, Drug Designing, Drug Delivery Systems, New Manufacturing technologies, Pharmaceutical Industry, Adverse Drug Reactions, Pharmaceutical Business
50.
 
Principles of Pharma Market Access in Europe
ID
834349
Termin
16. Mai 2017 - 17. Mai 2017
Ort
Zürich, Schweiz
Zusammenfassung
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
51.
 
Value Pricing for Market Access - The Fundamentals
ID
834388
Termin
18. Mai 2017 - 19. Mai 2017
Ort
Zürich, Schweiz
Zusammenfassung
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
52.
 
Biologistics World Korea 2017
ID
827175
Termin
23. Mai 2017 - 24. Mai 2017
Ort
Seoul, Republik Korea
Zusammenfassung
Biologistics World Korea is the MOST Targeted event in Korea that focuses on supply chain management and logistics for biologics and vaccines. Located in Singapore, the prime logistics hub of Korea, the programme promises to bring together key opinion leaders, rising players and market experts to discuss, debate and brainstorm on the most pertinent issues affecting Korea’s logistics network within a global context!
Kontakt
Andrew Darwitan;     Tel.: [+65 3109 0156];     Email: andrew.darwitan@imapac.com
53.
 
18th Annual Drug Discovery Summit
ID
845312
Termin
12. Jun 2017 - 13. Jun 2017
Ort
Berlin, Deutschland
Zusammenfassung
This summit brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective enabling technologies and solutions. Our co-located 5th Discovery Chemistry & Drug Design Congress provides an unprecedented opportunity to gain insights from key presenters of the computational chemistry, discovery chemistry and medicinal field.
Kontakt
Guillaume Alonso;     Tel.: [+44 (0) 1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Themen
drug discovery, screening, genomics, biotechnology, pharmaceutical, small molecule, large molecule, technologies
54.
 
Pharma Engineering 2017 — International Conference on Pharmaceutical and Biomedical Engineering
ID
852677
Termin
12. Jun 2017 - 13. Jun 2017
Ort
Taipei, Taiwan
Zusammenfassung
Conference Series LLC is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth “International Conference on Pharmaceutical and Biomedical Engineering” (Pharma Engineering 2017) scheduled to be held during June 12-13, 2017 at Taipei, Taiwan. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical and Biomedical Engineering.
Kontakt
Diya Sharan;     Tel.: [7025085200];     Email: pharmaengineering@pharmaceuticalconferences.com
Themen
Pharmaceutical Engineering, Biomedical Engineering, Pharmaceutical Technology, Pharmaceutical Formulations, Drug delivery, Drug Discovery, Genetic Engineering, Tissue Engineering, Bio Imaging, Process Engineering, Pharmaceutical Process Technology Novel drug deliveryNanotechnology Engineering
55.
 
10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
ID
831689
Termin
13. Jun 2017 - 15. Jun 2017
Ort
London, Großbritannien
Kontakt
Renaldo Hawell;     Email: renaldohowell179@gmail.com
Themen
Pharmaceutics/Formulation/Drug Delivery/Vaccine/Novel Drug Delivery
56.
 
Health Economics for Non-Health-Economists
ID
834373
Termin
20. Jun 2017 - 21. Jun 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
57.
 
Antibodies & Complement: Effector Functions, Therapies & Technologies
ID
781846
Termin
20. Jun 2017 - 23. Jun 2017
Ort
Albufeira, Portugal
Zusammenfassung
The antibody response and the complement system are major effector arms of the immune system. Both have been involved in a plethora of pathological conditions – including autoimmunity, allergy, infections and cancer- and regulate, mainly through their receptors (FcR and CR respectively) cell activation, migration, survival but also metabolism. As the portfolio of antibody- and complement-effector function grow, high-end technological solutions are developed and novel therapeutic applications are proposed.

This Zing conference will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts.

Verwandte Fachgebiete
58.
 
16th Annual Medicinal & Pharmaceutical Sciences Congress (Med Pharma Congress)
ID
852292
Termin
03. Jul 2017 - 05. Jul 2017
Ort
Kuala Lumpur, Malaysia
Zusammenfassung
Conference Series LLC invites all the participants across the globe to attend 16th Annual Medicinal & Pharmaceutical Sciences Congress during July 3-5, 2017 in Kuala Lumpur, Malaysia which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Med Pharma Congress is a specially designed cluster Pharma conference. The main theme of this Pharma conferences is “Developing the Synergy between Pharmaceutics and Medicinal Chemistry to Deliver Better Drugs” which covers a wide range of critically important sessions.
Themen
Medicinal Chemistry • Pharmacology • Chromatographic Techniques for Drug Analysis • Synthetic Organic Chemistry • Bio Pharmaceuticals • Pharmacogenomics • Pharmacognosy and Phytochemistry • Pharmaceutical Toxicology • Industrial Pharmacy
Verwandte Fachgebiete
59.
 
How to do Research on Therapeutic Interventions: Protocol Preparation
ID
828787
Termin
03. Jul 2017 - 07. Jul 2017
Ort
Oxford, Großbritannien
Zusammenfassung
The How to do Research on Therapeutic Interventions: Protocol Preparation course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the teaching will be led by Dr Grant D Vallance, Information Manager at the Oxford University Hospitals NHS Trust, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Kontakt
Course Administrator;     Tel.: [+44(0)1865 286955];     Email: expther@conted.ox.ac.uk
60.
 
9th World Congress on BA/BE Studies and Biowaivers
ID
849774
Termin
17. Jul 2017 - 19. Jul 2017
Ort
Melbourne, Australien
Zusammenfassung
Bioequivalence Congress is a 3-day event offering the Exhibition, at venue to showcase the new and emerging technologies and have wider sessions involving Keynote presentation, Oral, YRF ( student presentation), poster, e-poster presentations. World-renowned speakers and eminent delegates across the globe attending the conference, to share their valuable presentation on the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.
Kontakt
Daisy Pearl;     Tel.: [(702) 508-5200 Extn-8045];     Email: ba.beasia@pharmaceuticalconferences.org
Themen
drug research, generic drugs, bioequivalence, pharmacology, clinical pharmacology, bcs, biowaivers, pharmcodynamic studies, clinical trails, clinical research, FDA
61.
 
NanoPharma 2017 — 13th International Conference and Exhibition on Pharmaceutical Nanotechnology
ID
852403
Termin
24. Jul 2017 - 25. Jul 2017
Ort
Rom, Italien
Zusammenfassung
Currently we are bringing forth “13th International Conference and Exhibition on Pharmaceutical Nanotechnology” (NanoPharma 2017) scheduled to be held during July 24-25, 2017 at Rome, Italy. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Nanotechnology and Drug delivery.
Kontakt
Angela Mathews;     Tel.: [7025085200];     Email: nanopharma@pharmaceuticalconferences.org
Themen
drug delivery, nanoparticles, nanodrugs, nanomedicines, nanopharmaceuticals, pharmaceutical nanotechnology, liposomes, neosomes, erythrosomes
Verwandte Fachgebiete
62.
 
Asia Pharma 2017 — 10th Asia-Pacific Pharma Congress
ID
827412
Termin
24. Jul 2017 - 26. Jul 2017
Ort
Melbourne, Australien
Zusammenfassung
Asia Pharma 2017 is a perfect platform for scientists, decision-makers and students to come together, compare findings, and discuss the science of the future. Share your research with an engaged audience of your peers from around the globe; learn from scientific trail blazers who are designing more sustainable processes; find out how Pharmaceutical innovations are inspiring new businesses and product lines. Pharmaceutical sciences focus on the physiology and chemistry controlling drug therapeutic action in modern medicine. Often confused with pharmacy practice, pharmaceutics is distinct in its research and development emphasis, contributing important technologies and scientific bases for drug delivery to patients. Over half of newly discovered drug candidates cannot be commercialized without further drug delivery and formulation assistance. Researchers trained in pharmaceutics integrate a broad working knowledge of diverse scientific disciplines: from fundamental studies of drug physiochemical properties and bioactive molecules to mechanisms of various physiological processes that impact drug delivery to specific biological sites of action and, therefore, their therapeutic effectiveness. Increasing awareness of the complexity of the drug delivery process in living systems means that researchers in pharmaceutics today must maintain breadth and depth in physical chemistry, physical organic chemistry, bioengineering, nanotechnology and the life sciences in order to solve research problems that require integration basic science concepts from multiple disciplines with medical applications.
Kontakt
Robert Brown;     Tel.: [17025085200];     Email: asiapharma@pharmaceuticalconferences.com
Themen
Regulatory Affairs, Intellectual Property Rights, Pharmacognosy and Phytochemistry, Advancements in Pharmaceutics, Trends in Nanotechnology, Industrial Pharmacy, Pharmacological Studies, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutical Microbiology, Pharmaceutical Biotechnology, Biochemistry and Molecular Biology, Clinical Pharmacy, Hospital Pharmacy, Pharmaceutical Care & Health Systems, Pharma Compliance.
63.
 
Biosimilars Asia 2017 — 8th Asian Biosimilars Congress
ID
841156
Termin
14. Aug 2017 - 16. Aug 2017
Ort
Osaka, Japan
Zusammenfassung
Biosimilars Asia 2017 is a specially designed cluster conference. The main theme of the conference is
Kontakt
Victorya Jones;     Tel.: [7025085200];     Email: biosimilarsasia@pharmaceuticalconferences.com
Themen
biosimilars, biologics, biosimilars conference, biologics conferences, biosimilars events, Biologics events, biosimilars workshops
64.
 
Principles of Pharma Market Access in Europe
ID
834260
Termin
03. Okt 2017 - 04. Okt 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
65.
 
Value Pricing for Market Access - The Fundamentals
ID
834398
Termin
05. Okt 2017 - 06. Okt 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
66.
 
Health Economics for Non-Health-Economists
ID
834383
Termin
12. Okt 2017 - 13. Okt 2017
Ort
Zürich, Schweiz
Zusammenfassung
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
67.
 
The Health Technology Assessment Course - Trends & Opportunities in Europe
ID
834312
Beginn
30. Nov 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
68.
 
Principles of Pharma Market Access in Europe
ID
834292
Termin
05. Dez 2017 - 06. Dez 2017
Ort
London, Großbritannien
Zusammenfassung
Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
69.
 
Value Pricing for Market Access - The Fundamentals
ID
834353
Termin
07. Dez 2017 - 08. Dez 2017
Ort
London, Großbritannien
Zusammenfassung
Understand the language, the concepts and pricing research techniques in pharma – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
70.
 
Health Economics for Non-Health-Economists
ID
834459
Termin
14. Dez 2017 - 15. Dez 2017
Ort
Brüssel, Belgien
Zusammenfassung
Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.
Kontakt
Annelies Swaan;     Tel.: [+32027090142];     Email: annelies.swaan@celforpharma.com
Verwandte Fachgebiete
71.
 
Eilat XIV — Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices
ID
839649
Termin
13. Mai 2018 - 16. Mai 2018
Ort
Madrid, Spanien
Zusammenfassung
Based on the success of the past thirteen Eilat Conferences on New Antiepileptic Drugs and Devices (AEDs), the Organizing Committee takes pleasure in inviting you to participate in the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV), which will take place in Madrid, Spain, May 13 - 16, 2018.

For the forthcoming conference, we will be continuing with debates as well as adhering to the format of the previous conferences which are designed to provide an in-depth progress report on new antiepileptic drugs in various stages of development, as well as to present new findings on second-generation treatments.

Kontakt
Vikki Hyman;     Tel.: [+97235175150];     Email: eilat@target-conferences.com
Themen
epilepsy, antiepileptic, drugs, devices, treatments, conference, congress
Verwandte Fachgebiete
Pre-Filled Syringes Europe
RNA Therapeutics conference
Superbugs & Superdrugs Conference

Interessant...

Ihr Banner-Ad könnte an dieser Stelle erscheinen!

Stand vom 27. November 2016